NFKB1 and essential thrombocythemia: NF-κB signalling, triggered by oxidative stress, promotes pro-inflammatory cytokines and chemokines [40], and oxidative stress is elevated in ET patients with the JAK2V617F mutation who have experienced thrombotic episodes [27].